Background
==========

Chronic pain is a common reason for consultation in general practice. Current research distinguishes between chronic localized pain (CLP) and chronic widespread pain (CWP). CLP is defined as chronic pain restricted to one or few body regions (e.g. head, back, or knee). In contrast, CWP means chronic pain in several body regions. The American College of Rheumatology (ACR) defines CWP as pain in the left and right side of the body, as well as above and below the waist plus pain in the axial skeleton \[[@B1]\]. It is still unclear whether CWP is a complication of CLP or an independent pain syndrome \[[@B2]\].

Population based studies reported a CWP point-prevalence of 4.7%-15% depending on the country \[[@B3]-[@B8]\]. Nordeman et al. found a CWP prevalence of 28% in a sample of female chronic low back pain (CLBP) patients consulting primary care in Sweden \[[@B9]\]. The high CWP prevalence and the associated high social and economic burden for patients and health care systems \[[@B10]\] illustrate the need for further knowledge about CWP.

Several studies have investigated differences in physical and psychological factors between CWP patients and healthy adults: CWP patients are more frequently female, older, less educated \[[@B11]\], have a decreased health-related quality of life \[[@B7],[@B11]\], are less physically active \[[@B12]\], and a receive disability pension more often \[[@B13]\] than patients without pain. They show a high prevalence of physical and psychological comorbidities \[[@B4],[@B6],[@B14]-[@B17]\] and an increased mortality risk \[[@B18]\].

In addition to differences in the pain distribution, it is also important to know if CWP patients are more negatively affected in other wellbeing areas when compared to CLP patients.

To date, few studies have examined differences between CWP and CLP. Two studies present population based data on neck-shoulder pain \[[@B19]\] and myofacial face pain \[[@B20]\]. They found a higher rate of pain intensity, pain duration, depression, and somatization symptoms among CWP patients. Among all CLP syndromes, CLBP is the most common \[[@B21]\]. Back pain is the second most frequent consultation reason in German primary care practices \[[@B22]\].

Only one study investigated differences of CLBP and CWP in primary care patients: Nordeman et al. \[[@B9]\] found an increased rate of activity limitation, impaired physical performance, work disability, severe pain, tender points, fatigue, depression, and severe clinical stress symptoms in CWP patients compared to CLBP patients. The authors also reported a lower health-related quality of life and a reduced private social support in CWP patients \[[@B9]\]. However, Nordeman et al. studied only women.

The aim of this study is to identify differences between CWP and chronic low back pain (CLBP), a common type of CLP, in primary care settings. This would enable us to suggest priorities for health care interventions in CWP.

Methods
=======

Study design
------------

The present study refers to the cross sectional baseline analysis of a 12-month cohort study which evaluates risk factors and protective factors of pain generalization in primary care CLBP patients. A detailed study protocol has been published elsewhere \[[@B23]\].

This project is part of the research consortium LOGIN "Localized and Generalized Musculoskeletal Pain: Psychobiological Mechanisms and Implications for Treatment" funded by the German Federal Ministry of Education and Research. The study was approved by the local ethics commission of Philipps University in Marburg, Germany (Ethik: 11.06.2010, AZ 88/10) and is in accordance with the Declaration of Helsinki.

Study population
----------------

We invited all general practitioners (GPs) in the northern part of Germany's state of Hessen to participate in our study. We asked participating GPs to consecutively recruit all eligible patients consulting for CLBP as a primary or secondary consulting reason (inclusion criteria), during a 5-month period. The symptom "chronic low back pain" was defined as pain in the back area under the costal arch, but over the bottom fold (with or without pain radiation), during most days in the last three months. Patients under 18 years, pregnant women, and patients with insufficient understanding of the German language or severe cognitive impairments (e.g., dementia) were excluded from the study.

Data collection
---------------

Doctors asked patients for study participation directly after consultation. All participating patients received a pen and paper questionnaire. Patients who refrained from participation were asked to give reasons for their decline. During the recruitment period, trained clinical monitors conducted two random quality control checks of the GPs' performance.

Measurements
------------

To explore distinctive features with regards to pain characteristics and sociodemographic data between CLBP and CWP patients, we evaluated the following physical and psychological parameters (for detailed information please see Viniol et al. \[[@B23]\]).

### Pain characteristics and sociodemographic data

For definition of CLBP and CWP, we assessed pain localization with the body pain drawing model from Pfau et al. \[[@B24]\]. The CWP definition was derived from the ACR criteria from Wolfe et al. \[[@B1]\]. Pain anamnesis was assessed with the German Pain Questionnaire, the official pain questionnaire of the German Association for the Study of Pain \[[@B25]\]. We chose the modules referring to duration, characteristics, course of pain, sociodemographic data, health care utilization, and medication.

In addition, we used the 3-item social support subscale of the West Haven-Yale Multidimensional Pain Inventory (MPI) to explore the partner's reaction in response to patient's pain (internal consistency of the subscales: α = 0.63-0.90) \[[@B26],[@B27]\]. We rated the severity of chronic pain with the German translation of von Korff's Graded Chronic Pain questionnaire \[[@B28]\]. Severity is computed from "pain intensity" and "pain-related disability" (internal consistency of the subscales: α = 0.68-0.88). The lower range of the scale is determined by pain intensity; the higher range of the scale refers to pain intensity and pain-related disability \[[@B29]\].

### Comorbidities

Using the Self-Administered Comorbidity Questionnaire, we asked the patients about 14 common medical conditions (high blood pressure, heart disease, asthma, chronic obstructive pulmonary disease, ulcer/stomach disease, diabetes, high blood lipid level, kidney disease, osteoarthritis/degenerative arthritis, rheumatoid arthritis, osteoporosis, cancer disease, depression, other psychiatric diseases) \[[@B8],[@B30]\]. Patients were asked to specify if they suffer from any of these traits, whether they receive treatment for it, and whether it causes functional limitations.

### Psychosomatic symptoms

The Symptom Checklist-90-R (SCL-90-R) assess typical physical symptoms which accompany functional dysfunctions, but could also arise in somatic disorders.

The SCL-90-R is a commonly used psychological status symptom inventory for psychopathology (internal consistency: α = 0.81) \[[@B31]\].

General practitioners case report
---------------------------------

Potential red flags, which are frequently used risk factors for identifying serious disorders causing low back pain, were documented by the GPs for each patient \[[@B32]\].

Statistical analysis
--------------------

We calculated summary statistics (mean, median, standard deviation, percentiles, frequencies, and percentages) for each of the two study groups, i.e., CWP and CLBP.

Testing for differences in outcome variables between CWP and CLBP patients was done using chi-square tests (for categorical data with expected cell frequencies of n ≥ 5), Fisher's exact tests (for categorical data with expected cell frequencies of n \> 5), t-tests accounting for unequal variances (Welsh tests), and Mann--Whitney U tests (for ordinal data).

Results
=======

Enrollment of general practitioners and patients
------------------------------------------------

Fifty-eight of the 284-invited GPs (20.4%) participated in the study. The majority of them were male (58.6%), averaged 53 years old, and worked in practices with differing sizes from both urban and rural locations and having varying organizational structures (solo/group practices).

During the recruitment period, 746 eligible patients were asked to participate. Seventy-six patients declined participation at once, and fifteen patients withdrew consent when seeing the questionnaire. Therefore, 655 participants completed the questionnaire. We excluded eight additional subjects from analyses because they did not report lower back pain on the pain drawing. A total of, 647 patients were analysed.

Total group characteristics
---------------------------

A quarter of all participating CLBP patients (163, 25.2%) met CWP criteria in the pain drawing. The majority (52.1%) of all CLBP patients reported having back pain for more than ten years. On average, the participating patients were 56.5 years old. The majority was female (61.6%), married (65.1%), and lived in a two-person household (48.6%). Half of the participants are working (50.5%). Of the non-working participants, 75.2% were retired.

Differences between CLBP and CWP patients
-----------------------------------------

### Sociodemographic data

A higher fraction of females was observed among CWP patients compared to CLBP patients (CWP 71.8% vs. CLBP 57.6%). CWP patients were less working (CWP 52.8% vs. CLBP 43.6%). Reasons for not working were comparable between groups. CWP patients more frequently reported a current pension application (CWP 14.1% vs. CLBP 5.2%) and having a degree of disability (CWP 54.2% vs. CLBP 38.5%). Other sociodemographic parameters such as age, marital status, education and reasons for not working, showed no differences between the two groups. For a detailed description of the sociodemographic data see Table [1](#T1){ref-type="table"}.

###### 

Sociodemographic data: differences between CLBP and CWP (n = 647)

                                                   **CLBP**       **CWP**     **p**                  
  ---------------------------------------------- ------------- ------------- ------- ------- ------- ----
  **Sex** \[no. (%)\]                               n = 484       n = 163     0.002    \-      \-     \-
  Female                                          279 (57.6)    117 (71.8)                             
  **Age** \[years: mean (SD)\]                      n = 484       n = 163      \-      \-     0.573   \-
                                                  56.3 (14.4)   57.0 (12.6)                            
  **Marital status** \[no. (%)\]                    n = 484       n = 163     0.128    \-      \-     \-
  Single                                           61 (12.6)     22 (13.5)                             
  Married                                         326 (67.4)     95 (58.3)                             
  Divorced                                         54 (11.2)     28 (17.2)                             
  Widowed                                          43 (8.9)      18 (11.0)                             
  **Level and years of education** \[no. (%)\]      n = 482       n = 163      \-     0.425    \-     \-
  13/12 years                                      70 (14.5)     31 (19.0)                             
  10 years                                        148 (30.7)     45 (27.6)                             
  9 years                                         251 (52.1)     81 (49.7)                             
  Other graduation                                 11 (2.3)       4 (2.5)                              
  No qualification                                  2 (0.4)       2 (1.2)                              
  **Employment status** \[no. (%)\]                 n = 481       n = 163     0.046    \-      \-     \-
  Working (full or part-time)                     254 (52.8)     71 (43.6)                             
  **Reasons for not working** \[no. (%)\]           n = 223       n = 92       \-     0.796    \-     \-
  Keeping house                                    35 (15.7)     13 (14.1)                             
  Retired                                         167 (74.9)     70 (76.1)                             
  Unemployed                                       18 (8.1)       9 (9.8)                              
  Other                                             3 (1.3)        0 (0)                               
  **Applied for pension** \[no. (%)\]               n = 401       n = 128     0.002    \-      \-     \-
  Yes                                              21 (5.2)      18 (14.1)                             
  **Degree of disability** \[no. (%)\]              n = 457       n = 153     0.001    \-      \-     \-
  Yes                                             176 (38.5)     83 (54.2)                             

### Pain characteristics

The majority of CWP patients (61.3%) and 49.0% in the CLBP group reported long-lasting pain for more than ten years. While CLBP patients tended to have more pain attacks with pain-free time periods, CWP subjects suffered more frequently from permanent pain. With regards to the severity of chronic pain, we did not find significant differences between the groups. Similarly, no differences were found for the social support scale of the MPI or for the frequency of red flags between CWP and CLBP patients. More details about the pain characteristics are shown in Table [2](#T2){ref-type="table"}.

###### 

Pain anamnesis: differences between CLBP and CWP (n = 647)

                                                           **CLBP**     **CWP**      **p**                
  ------------------------------------------------------ ------------ ------------ --------- ---- ------- ---------
  **Pain in the following areas** \[no. (%)\]              n = 484      n = 163                                
  Head                                                     30 (6.2)    51 (31.3)    \>0.001   \-    \-       \-
  Cervical spine                                          161 (33.3)   125 (76.7)   \>0.001   \-    \-       \-
  Thoracic spine                                          198 (40.9)   115 (70.6)   \>0.001   \-    \-       \-
  Lumbar spine                                            484 (100)    163 (100)      \-      \-    \-       \-
  Sternum                                                  12 (2.5)     15 (9.2)     0.001    \-    \-       \-
  Arm -- left                                             76 (15.7)    141 (86.5)   \>0.001   \-    \-       \-
  Arm -- right                                            97 (20.0)    148 (90.8)   \>0.001   \-    \-       \-
  Leg -- left                                             160 (33.1)   140 (85.9)   \>0.001   \-    \-       \-
  Leg -- right                                            169 (34.9)   145 (89.0)   \>0.001   \-    \-       \-
  Stomach                                                 67 (13.8)    69 (42.3)    \>0.001   \-    \-       \-
  **Number of pain areas** \[mean (SD)\]                   n = 484      n = 163       \-      \-    \-     \>0.001
                                                          3.0 (1.6)    6.8 (1.5)                               
  **Body mass index** \[mean (SD)\]                        n = 472      n = 162       \-      \-   0.433     \-
                                                          28.1 (5.8)   28.6 (5.9)                              
  **First time of back pain** \[no (%)\]                   n = 484      n = 163       \-      \-    \-     \>0.001
  Since \> 1 year ago                                     70 (14.5)     9 (5.5)                                
  1-2 years ago                                            41 (8.5)     6 (3.7)                                
  2-5 years ago                                           67 (13.8)    20 (12.3)                               
  5-10 years ago                                          69 (14.3)    28 (17.2)                               
  \> 10 years ago                                         237 (49.0)   100 (61.3)                              
  **Back pain frequency** \[no (%)\]                       n = 480      n = 163       \-      \-    \-     \>0.001
  Few times per year                                       40 (8.3)     1 (0.6)                                
  Few times per month                                      47 (9.8)     10 (6.1)                               
  Several times per week                                  89 (18.5)    21 (12.9)                               
  One time daily                                           16 (3.3)     2 (1.2)                                
  Several times per day                                   99 (20.6)    27 (16.6)                               
  Permanent                                               189 (39.4)   102 (62.6)                              
  **Pain distribution** \[no (%)\]                         n = 480      n = 163      0.001    \-    \-       \-
  Permanent pain with slight variations                   98 (20.4)    42 (25.8)                               
  Permanent pain with higher variations                   142 (29.6)   57 (35.0)                               
  Pain attacks, between pain free                         164 (34.2)   28 (17.2)                               
  Pain attacks, between pain                              76 (15.8)    36 (22.1)                               
  **Duration of pain attacks** \[no (%)\]                  n = 232       n = 62       \-      \-    \-      0.013
  Seconds/minutes                                         41 (17.7)     6 (9.7)                                
  Hours                                                   78 (33.6)    22 (35.5)                               
  Days                                                    36 (15.5)    12 (19.4)                               
  Longer than 3 days                                      39 (16.8)     7 (11.3)                               
  Longer than 1 week                                      38 (16.4)    15 (24.2)                               
  **Red flags** \[no (%)\]                                 n = 479      n = 161      0.224    \-    \-       \-
  Positive                                                89 (18.6)    37 (23.0)                               
  **MPI - social support subscale** \[mean (SD)\]          n = 475      n = 141       \-      \-   0.234     \-
                                                          4.8 (1.9)    4.6 (1.9)                               
  **Graded Chronic Pain (von Korff Index)** \[no (%)\]      n= 447      n = 148       \-      \-    \-      0.109
  0                                                         0 (0)        0 (0)                                 
  1                                                       72 (16.1)     11 (7.4)                               
  2                                                       109 (24.4)   39 (26.4)                               
  3                                                       131 (29.3)   50 (33.8)                               
  4                                                       135 (30.2)   48 (32.4)                               
  **Gut feeling: Will the pain go away?** \[no (%)\]       n = 464      n = 156     \>0.001   \-    \-       \-
  Yes                                                     228 (49.1)   48 (30.8)                               

### Health care

CWP patients \[mean (SD) 7.3 (4.1)\] received a significantly higher number of different therapeutic strategies compared to CLBP patients \[mean (SD) 5.7 (3.6)\]. However, we found no differences in the number of GP consultations, the number of different doctors consulted, and stays in hospital during a six-month period prior to recruitment.

### Comorbidities and psychosomatic symptoms

In general, the CWP group showed a higher number of comorbidities referring to a higher frequency of ulcer/stomach disease, kidney disease, osteoarthritis/degenerative arthritis, rheumatoid arthritis, and depression. In comparison to CLBP patients, CWP patients suffered more often from psychosomatic symptoms. All data are shown in Table [3](#T3){ref-type="table"}.

###### 

Comorbidities + psychosomatic symptoms: differences between CLBP and CWP (n = 647)

                                                      **CLBP**     **CWP**      **p**                  
  ------------------------------------------------- ------------ ------------ --------- ---- --------- -------
  **Disease areas (problems)** \[no (%)\]                                                                  
  High blood pressure (n = 632)                       n = 472      n = 160      0.079    \-     \-       \-
                                                     210 (44.5)   84 (52.5)                                
  Heart diseases (n = 611)                            n = 460      n = 151      0.489    \-     \-       \-
                                                     57 (12.4)    22 (14.6)                                
  Asthma (n = 608)                                    n = 458      n = 150      0.730    \-     \-       \-
                                                     65 (14.2)    23 (15.3)                                
  Chronic obstructive pulmonary disease (n = 594)     n = 450      n = 144      0.862    \-     \-       \-
                                                     46 (10.2)     14 (9.7)                                
  Ulcer or stomach diseases (n = 605)                 n = 455      n = 150      0.014    \-     \-       \-
                                                     77 (16.9)    39 (26.0)                                
  Diabetes (n = 609)                                  n = 462      n = 147      0.763    \-     \-       \-
                                                     61 (13.2)    18 (12.2)                                
  High blood lipid level (n = 607)                    n = 454      n = 153      0.272    \-     \-       \-
                                                     130 (28.6)   51 (33.3)                                
  Kidney diseases (n = 602)                           n = 454      n = 148      0.011    \-     \-       \-
                                                      33 (7.3)    21 (14.2)                                
  Osteoarthitis, degenerative arthritis (n = 619)     n = 462      n = 157     \>0.001   \-     \-       \-
                                                     192 (41.6)   96 (61.1)                                
  Rheumatoid arthritis (n = 591)                      n = 445      n = 146      0.005    \-     \-       \-
                                                     48 (10.8)    29 (19.9)                                
  Osteoporosis (n = 597)                              n = 447      n = 150      0.454    \-     \-       \-
                                                      44 (9.8)    18 (12.0)                                
  Cancer disease (n = 600)                            n = 453      n = 147      0.287    \-     \-       \-
                                                      33 (7.3)     7 (4.8)                                 
  Depression (n = 598)                                n = 456      n = 142     \>0.001   \-     \-       \-
                                                     84 (18.4)    47 (33.1)                                
  Other psychiatric diseases (n = 596)                n = 449      n = 147      0.354    \-     \-       \-
                                                     54 (12.0)    22 (15.0)                                
  Number of diagnosed problems \[mean (SD)\]          n = 383      n = 118                                 
                                                     2.2 (1.9)    2.9 (2.1)      \-      \-     \-      0.001
  Number of treated problems \[mean (SD)\]            n = 366      n = 107                                 
                                                     1.3 (1.5)    1.8 (1.9)      \-      \-     \-      0.026
  Summary score \[mean (SD)\]                         n = 331      n = 102                                 
                                                     3.5 (3.6)    5.0 (4.6)      \-      \-    0.003     \-
  Symptom Checklist-90-R                              n = 430      n = 143                                 
  Summation of all items \[mean (SD)\]               10.0 (5.9)   15.0 (7.6)     \-      \-   \>0.001    \-
  Mean of all items \[mean (SD)\]                    0.8 (0.5)    1.3 (0.6)      \-      \-   \>0.001    \-
  Number of symptoms \[mean (SD)\]                   5.6 (2.8)    7.8 (3.0)      \-      \-   \>0.001    \-

Discussion
==========

To our knowledge, this project is the largest study to date which analyzes differences between chronic localized low back pain and chronic widespread pain in primary care settings.

A quarter of all included CLBP patients satisfy the ACR criteria for CWP. Altogether, CWP patients are predominantly female and showed more psychosomatic symptoms and comorbidities than CLBP patients.

The observed high prevalence of CWP (25.2%) is in accordance with the findings of Nordeman et al., who reported a CWP prevalence of 28% in females in primary care settings \[[@B9]\]. The slightly higher prevalence in the study of Nordeman et al. can be explained by the female sample, which is associated with higher risk for CWP \[[@B7],[@B11]\].

Apart from the apparently higher proportion of females in the CWP group, which confirms similar findings of other investigators \[[@B7],[@B11]\], we found no group differences in other sociodemographic data. Again, this observation is in accordance with the findings of Nordeman et al. They found no significant differences in the following sociodemographic parameters: age, nationality, education, and social status between female CLBP and CWP patients.

In contrast, a population-based study from Bergman et al. found a lower educational and social status among CWP patients \[[@B11]\]. There is no clear reason for this contrast. A possible explanation could be the different setting of the populations in the study (primary care vs. population based) and that Bergman et al. compared CWP versus chronic regional pain in general.

The role of somatization processes in CWP is still unclear. In the literature, two hypotheses are discussed: First, somatization could be a consequence of CWP. Second, CWP could be a manifestation of the process of somatization \[[@B11]\]. We only assessed typical physical symptoms which accompany functional dysfunctions; these symptoms could also arise in somatic disorders. The increased prevalence of these symptoms in the CWP group emphasizes a slight association between CWP and the process of somatization \[[@B33]\]. Although we cannot make any causal attributions due to the cross-sectional nature of our data, population-based cohort studies showed somatic symptoms to be a predictive factor for the onset of CWP \[[@B34],[@B35]\]. This supports the hypothesis: CWP is a manifestation of the somatization process.

In comparison to individuals without back pain \[[@B8]\], our total study population has an increased prevalence of comorbidities. The increased rates of osteoarthritis and degenerative arthritis, rheumatoid arthritis, depression, ulcer or stomach diseases, and kidney diseases among CWP patients correspond with the observations of Kato et al. \[[@B15]\]. They extracted CWP cases and their healthy siblings from the Swedish Twin Registry and assessed their comorbidities. A comparative analysis showed that CWP patients have an increased odds ratio for having joint pain, depressive symptoms, irritable bowel syndrome, and chronic fatigue syndrome.

The increased rates of ulcer/stomach and kidney diseases in our CWP sample might be related to a higher consumption of non-steroidal anti-inflammatory drugs (NSAID). Furthermore, ulcer and stomach diseases are typical symptoms of somatization processes as discussed above \[[@B36]\]. Apart from this, depression is a well-known comorbidity of CWP \[[@B36]\]. GPs should immediately consider the parallel comorbidities while treating CWP patients.

The definition of chronic widespread pain comprises duration and local extension of the pain \[[@B1]\]. It is an operational definition on a symptomatic level which does not allow for any conclusions with respect to the aetiology of CWP. Consequently, it is impossible to differentiate between patients with multiple regional pain and patients who experience a generalization of their pain by somatic causes (e.g. arthrosis in joint, hallux valgus). With a sensitivity of 98% and a specificity of 31% of the current definition from the ACR \[[@B37]\], it is most likely that there is a high proportion of patients in our sample that suffers from multiple regional pain since the majority of patients in general practices are older and suffer from multimorbidity, including degenerative diseases. However, based on epidemiological findings, Macfarlane postulated that a differentiation of these would be artificial and obscuring important aspects of aetiology \[[@B37]\].

In discussing group differences, we must emphasize that our study population is comprised of patients with a severe disease pattern (52%: pain \> 10 years). Therefore, we assume that our subgroups do not greatly differ due to the already extreme nature of our subjects. This might also be a reason for the similarity of CLBP and CWP patients regarding pain severity according to von Korff \[[@B28]\]. Both groups showed high rates of "pain related disability", which forms the upper two grades of severity independent of the dimension "pain intensity".

With respect to methodological limitations, we have to think of selection bias in our study. In our study, some participations denied participation due to the long, demanding questionnaire. Selective recruitment might have occurred because general practitioners might forget to recruit patients due to a high workload. Furthermore, it might be possible that GPs are more likely to recruit special cases (e.g., patients with higher disease severity or unique personality). This might reduce the external validity of our results.

Although a GP recruitment rate of about 20% is normal in our research field, we should consider selection bias. We do not know if non-participating GPs have CLBP patients with characteristics different than the participating GPs. However, regarding sociodemographic data and practice characteristics, the GP sample seems to be representative for the region of northern Hessen.

Conclusion
==========

Our primary finding is the high CWP prevalence among CLBP patients in primary care settings. Therefore, CWP is a frequent and particularly severe pain syndrome. Although it is impossible to identify CWP patients with the help of typical sociodemographic profiles, we showed that CWP patients are more likely to suffer from psychosomatic symptoms and comorbidities than CLBP patients. These comorbidities must be considered when a GP makes treatment decisions based on the fact that a patient has CWP. Further research is needed to clarify the role of somatization in conjunction with chronic widespread pain to infer the direction of causality.
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